CEO, Oasis Diagnostics, USA
Dr. Slowey is the Founder and Owner of Oasis Diagnostics® Corporation and its subsidiary Company, Bamburgh Marrsh LLC, founded in 2002, each are pioneers in the area of oral fluid diagnostics and testing. Dr Slowey’s background is in Organic Chemistry; after being awarded his Doctorate from the University of Newcastle-upon-Tyne (UK), he spent several years as a Post Doctoral Fellow in Canada then 5 years in the pharmaceutical industry with Sterling Drug [UK]. He has over 32 years of experience in the clinical diagnostic and pharmaceutical industries combined. Over the years he has held positions as Director of International Sales and Chief Operating Officer (COO) and Vice President of Sales and Marketing for companies that were the original pioneers in the development of saliva diagnostic rapid tests for infectious diseases, and oral fluid collection devices. He has extensive experience in structuring strategic alliances and license agreements with both start-up and Fortune 500 companies. Dr Slowey has 30 publications in peer-reviewed journals, fifteen (15) issued patents, twelve (12) filed patent applications and he has made a number of oral presentations at key scientific symposia on a variety of subjects including HIV diagnosis, nucleic acid testing, the status of oral fluid testing, the Japanese Healthcare Business and Thyrotropin Receptor Antibody Assays for the Diagnosis of Graves’ Disease.
Dr Slowey is the Founder and Co-Organizer of the North American Saliva Symposium [NASS, www.salivasymposium.com ] and is a Director of a teaching college in Kampala, Uganda [Bridgeford College].
Cheif of Pediatrics, Women & Infants Hospital, Brown University, USA
In June of 2021, Care New England announced the appointment of Jill L. Maron, MD, MPH, to Chief of Pediatrics at Women & Infants Hospital. We enthusiastically welcomed Dr. Maron into our Department of Pediatrics on October 1, 2021. She serves as the Oh-Zopfi Endowed Chair of Pediatrics at The Warren Alpert Medical School of Brown University.
Previously, Dr. Maron served as the Vice Chair of Pediatric Research and Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Children’s Hospital.
Dr. Maron comes to Women & Infants Hospital with a wealth of experience, and someone who is regarded as a well-respected expert in her field. She has been a gifted clinician, researcher and mentor at Tufts MC since finishing her fellowship in Newborn Medicine in 2006. In the past 15 years, she has built a strong reputation as an international leader in the development and integration of salivary and genetic diagnostic platforms to rapidly assess genetic disorders, neonatal morbidities and potential developmental disorders in newborns. Dr. Maron also currently serves as Principal Investigator (PI) on three NIH-funded multicenter clinical trials. She has published extensively in the field. She also serves as Professor of Pediatrics at Tufts University School of Medicine, with a secondary Professorship appointment in Obstetrics & Gynecology.
In 2016, Dr. Maron became Executive Director of MIRI when its founder and long-standing mentor, Dr. Diana Bianchi, was tapped to direct the National Institute of Child Health and Human Development at the National Institutes of Health (NIH). Over the five years since, Dr. Maron has transformed MIRI into a first-in-kind research center to address all aspects of pregnancy by expanding its maternal and neonatal research focus to include placental biology and pathology. She has doubled the number of talented researchers and grown the funded research portfolio by over 500 percent. Through Dr. Maron’s stewardship, MIRI is now well poised to continue to make important discoveries that advance health care for pregnant women and their infants.
She will continue her research endeavors, creating her own research institute at Women & Infants Hospital and looks forward to strengthening the neonatal academic and clinical mission at Brown.
Universidaid La Rioja, Spain
Dr. Manuel Jiménez is an Assistant Professor in the Department of Didactics in Physical Education and Health and of the department of educational psychology and psychobiology of the Faculty of Education (International University of La Rioja, Spain). He is a professor of the Master’s degree at the University of Malaga. He has been an Honorary Research Fellow at the University College of London. He is the coordinator of the Brain-Gamer project that analyzes the core responses of esports players. He has been the national coach of badminton of the Spanish team and has been a coordinator of the Ministry of Education and a member of the Canary Youth Council (Spain). Dr Manuel won the prize “Dr Fernández Pastor” for the best publication in sports medicine in 2012 and was a finalist in 2013.
Research Scientist at Epidemiology of Microbial Diseases Yale School of Public Health, USA
Anne Wyllie, Ph.D. is a Research Scientist and Principal Investigator of SalivaDirect at Yale University. Having worked with saliva as a clinical specimen for bacterial detection for over 10 years, Wyllie is an expert in the laboratory methods required for working with saliva and skillfully applied these early in the pandemic for sensitive SARS-CoV-2 detection. Since, Wyllie has become well-recognized for pushing forward on the use of saliva as a superior sample for creating high-quality, low-cost SARS-CoV-2 testing. Her innovation throughout the pandemic, and her commitment to open science has led to the development of freely, available PCR protocols, enabling laboratories across the US to rapidly implement accessible COVID-19 testing programs. Wyllie’s SalivaDirect Initiative at the Yale School of Public Health remains devoted to providing public health guidance and advancing saliva-based diagnostics for infectious disease.
Universidade Cruzeiro do Sul, Sao Paulo, Brazil
Dr. Debora Heller is a dental scientist and Assistant Professor in Dentistry at Universidade Cruzeiro do Sul and Researcher at Hospital Israelita Albert Einstein, São Paulo, Brazil. She has a PhD in Oral biology from Boston University, a MSc from Universidade Federal do Rio de Janeiro and DDS from Universidade Federal do Rio Grande do Sul, Brazil. She leads the Saliva Lab, a salivary research laboratory in São Paulo, Brazil. She is currently a Councilor for the IADR Salivary Research Group (2018-2021) and a member of the IADR Science Information Committee (2020-2021) and the Woman in Science Network.
University of Adelaide, Australia
Wayne Leifert is a Principal Research Scientist at CSIRO (Australia). He received his PhD in Nutritional Biochemistry (Dept of Physiology) from the University of Adelaide (Australia) and serves on the editorial board of the Journal of Biomolecular Screening, Expert Opinion on Drug Discovery, Journal of Bionanoscience and Frontiers in Nutrigenomics as well as other journals in the field of medical biochemistry. He has affiliate status at Flinders University (College of Medicine and Public Health) and is an Honorary Associate Professor at the University of Adelaide (Molecular & Biomedical Science).
Deakin University, Australia
Prof Jeff Craig studies the role of epigenetics in mediating the effects of early life environment on chronic disease risk. His expertise also includes twin studies and birth cohorts.
Professor Jeff Craig is a lecturer in Medical Sciences at School of Medicine at Deakin University, Waurn Ponds, Victoria. He has a BSc in Genetics and Cell Biology from the University of Manchester, a PhD from the University of Edinburgh and a Grad. Cert. in Higher Education Learning and Teaching from Deakin. His research goal is to apply techniques of epigenetics and cell biology to develop biomarkers of health and disease. This includes a focus on the role of epigenetics in mediating the effects of early life environment on the risk for chronic conditions.
Prof Craig is the Course Director for the Bachelor of Health and Medical Sciences at Deakin‘s School of Medicine. He also lectures to several undergraduate courses at Deakin and other universities. He bases his teaching philosophy on knowledge, innovation, support and trust. He aims to inspire and train students with skills that will enable them to be job ready. And to think, reflect, challenge, and discover their innate skills.
Prof Craig has established many longitudinal cohorts in collaboration with clinicians and epidemiologists. Most have involved twins because of their ability to resolve the effects of genes and environments. His longest-running cohort is the Peri/postnatal Epigenetic Twin Study (PETS). He is currently funded by the NHMRC to study cognition and brain structure & function in 11-year-old PETS twins. Prof Craig is a Chief Investigator on the NHMRC-funded Twins Centre of Research Excellence. He is also the President of the International Society for Twin Studies and an advocate for twins and their families.
In 2018 Prof Craig established the multidisciplinary network ‘Gen(e)quality’. Its broad aim is to develop ideas on the technical, ethical, legal and social implications of epigenetics research and testing. A specific, current aim of Gen(e)quality is to engage with sections of the public to co-design guides on epigenetics and epigenetic testing.
Prof Craig is an active science communicator and over one million people have read his articles in The Conversation. He is also interested in the two-way interactions between human health and the health of the environment.
Imperial College London, England
Dr Chi Udeh-Momoh is a Neuroscientist based at Imperial College London, and affiliated as a Senior Scientist with Karolinska Institutet and University of Bristol. She is co-Investigator and scientific coordinator of one of the world’s largest longitudinal dementia-prevention programmes (CHARIOT:PRO) with > 2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput. In 2018, she initiated the FINGER-AFRICA project that aims to develop and implement culturally-sensitive and sustainable multimodal lifestyle intervention strategies targeting multi-morbidities including dementia, in Sub-Saharan African populations, and investigate underlying mechanisms contributing to observed effects, with European, US and African collaborators. Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol, her current research focuses on the brain-immune-endocrine system interplay in the aetiology and pathophysiology of neurocognitive disorders, particularly Alzheimer’s disease. She is co-Lead for the World-Wide FINGERS biomarker consortium, and sits on the Executive Committee of the Biofluids-based Professional Interest Area for Alzheimer’s Association facilitating several biomarker workgroups, including the saliva biomarkers for dementia and exosome work group. She uses translational research methodologies to address gaps in current understanding of underlying bio-psychosocial factors involved in manifestation of pathology and resultant presentation of clinical symptoms, primarily in the context of brain and cognitive reserve-related mechanisms, also evaluating sex/gender differences in risk factors and biological pathways; and has published as lead, senior and corresponding author in this field, with several grants and awards to execute this work. She is incredibly passionate about gender and racial disparities in medical research and academia; and alongside research in this area leads diversity initiatives as part of the Opportunity Committee at Imperial College School of Public Health, and further sits on the Board of Trustees of the British Society of Neuroendocrinology as the Equality and Diversity Inclusion Lead.
K M Shah Dental College, India
Dr.Vandana Shah is Professor & Head, Department of Oral Maxillofacial Pathology, K M Shah Dental College & Hospital, Gujarat. She became the faculty at KMSDCH since 1999. She is Fellow of the College conferred by International College of Continuing Dental Education in July 2013 and NDDSF State representative in March 2015 She has published more than 30 publications in areas of oral Pathology & Microbiology and has been organizing Chairperson of various CDE Program, Symposium and Conventions. She also serves as editorial board members for several journals, committee member of Academic Council, Institutional Ethics Committee and Director Students’ Welfare of Sumandeep Vidyapeeth University. She is a mentor and guide for postgraduate students and PhD scholars.
Dr. Apurva Garg is a superspecialist Head and Neck oncosurgeon with over 14 years experience in evidence based comprehensive cancer care. He has been trained at the world renowned Tata Memorial Hospital Mumbai followed by consultancy at premier high volume tertiary oncology centers across India. He has helped transform many lives with ethical, scientific, comapassionate and best in class care. He has numerous research publications, presentations at national and international levels. Dr. Garg has wide global exposure of the superspeciality with keen interest in clinical research, academics, public health and mentoring new talents.